Pavlos Bobos1, Goris Nazari2, Mike Szekeres3, Emily A Lalone4, Louis Ferreira5, Joy C MacDermid6. 1. Department of Health and Rehabilitation Sciences, Western's Bone and Joint Institute, Western University, London, ON, Canada. Electronic address: pbobos@uwo.ca. 2. Department of Health and Rehabilitation Sciences, Western's Bone and Joint Institute, Western University, London, ON, Canada. 3. Hand Therapy Canada, London, ON, Canada. 4. Faculty of Engineering, Department of Mechanical and Materials Engineering, Western University, ON, Canada. 5. Roth | McFarlane Hand & Upper Limb Centre (HULC) St. Joseph's Health Care, London, ON, Canada. 6. Physical Therapy and Surgery, Western University, London, ON and Co-director Clinical Research Lab, Hand and Upper Limb Centre, St. Joseph's Health Centre, London, ON; Rehabilitation Science McMaster University, Hamilton, ON, Canada.
Abstract
STUDY DESIGN: Systematic review with meta-analysis. INTRODUCTION: Joint protection (JP) has been developed as a self-management intervention to assist people with hand arthritis to improve occupational performance and minimize joint deterioration over time. PURPOSE OF THE STUDY: We examined the effectiveness between JP and usual care/control on pain, hand function, and grip strength levels for people with hand osteoarthritis and rheumatoid arthritis. METHODS: A search was performed in 5 databases from January 1990 to February 2017. Two independent assessors applied Cochrane's risk of bias tool, and a Grading of Recommendations Assessement, Development and Evaluation (GRADE) approach was adopted. RESULTS: For pain levels at short term, we found similar effects between JP and control standardized mean difference (SMD; -0.00, 95% confidence interval [CI]: -0.42 to 0.42, I2 = 49%), and at midterm and long-term follow-up, JP was favored over usual care SMD (-0.32, 95% CI: -0.53 to -0.11, I2 = 0) and SMD (-0.27, 95% CI: -0.41 to -0.12, I2 = 9%), respectively. For function levels at midterm and long-term follow-up, JP was favored over usual care SMD (-0.49, 95% CI: -0.75 to -0.22, I2 = 34%) and SMD (-0.31, 95% CI: -0.50 to -0.11, I2 = 56%), respectively. For grip strength levels, at long term, JP was inferior over usual care mean difference (0.93, 95% CI: -0.74 to 2.61, I2 = 0%). CONCLUSIONS: Evidence of very low to low quality indicates that the effects of JP programs compared with usual care/control on pain and hand function are too small to be clinically important at short-, intermediate-, and long-term follow-ups for people with hand arthritis.
STUDY DESIGN: Systematic review with meta-analysis. INTRODUCTION: Joint protection (JP) has been developed as a self-management intervention to assist people with hand arthritis to improve occupational performance and minimize joint deterioration over time. PURPOSE OF THE STUDY: We examined the effectiveness between JP and usual care/control on pain, hand function, and grip strength levels for people with hand osteoarthritis and rheumatoid arthritis. METHODS: A search was performed in 5 databases from January 1990 to February 2017. Two independent assessors applied Cochrane's risk of bias tool, and a Grading of Recommendations Assessement, Development and Evaluation (GRADE) approach was adopted. RESULTS: For pain levels at short term, we found similar effects between JP and control standardized mean difference (SMD; -0.00, 95% confidence interval [CI]: -0.42 to 0.42, I2 = 49%), and at midterm and long-term follow-up, JP was favored over usual care SMD (-0.32, 95% CI: -0.53 to -0.11, I2 = 0) and SMD (-0.27, 95% CI: -0.41 to -0.12, I2 = 9%), respectively. For function levels at midterm and long-term follow-up, JP was favored over usual care SMD (-0.49, 95% CI: -0.75 to -0.22, I2 = 34%) and SMD (-0.31, 95% CI: -0.50 to -0.11, I2 = 56%), respectively. For grip strength levels, at long term, JP was inferior over usual care mean difference (0.93, 95% CI: -0.74 to 2.61, I2 = 0%). CONCLUSIONS: Evidence of very low to low quality indicates that the effects of JP programs compared with usual care/control on pain and hand function are too small to be clinically important at short-, intermediate-, and long-term follow-ups for people with hand arthritis.
Authors: Pavlos Bobos; Joy C MacDermid; Goris Nazari; Emily A Lalone; Louis Ferreira; Ruby Grewal Journal: Physiother Can Date: 2021 Impact factor: 1.037
Authors: Pablo Rodríguez Sánchez-Laulhé; Luis Gabriel Luque-Romero; Francisco José Barrero-García; Ángela Biscarri-Carbonero; Jesús Blanquero; Alejandro Suero-Pineda; Alberto Marcos Heredia-Rizo Journal: JMIR Mhealth Uhealth Date: 2022-04-07 Impact factor: 4.947
Authors: Pavlos Bobos; Joy C MacDermid; Eleni C Boutsikari; Emily A Lalone; Louis Ferreira; Ruby Grewal Journal: Health Qual Life Outcomes Date: 2020-09-09 Impact factor: 3.186
Authors: Juliane K Stöcker; Anne A Schouffoer; Julia Spierings; Marisca R Schriemer; Judith Potjewijd; Lian de Pundert; Frank H J van den Hoogen; Maria W G Nijhuis-van der Sanden; J Bart Staal; Ton Satink; Madelon C Vonk; Cornelia H M van den Ende Journal: Rheumatology (Oxford) Date: 2022-04-11 Impact factor: 7.580